Loading clinical trials...
Loading clinical trials...
Evaluation of Safety and Feasibility of Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) for Solid Pancreatic Neoplasms
Conditions
Interventions
EUSRA RFA needle
Locations
1
Singapore
Singapore General Hospital
Singapore, Singapore
Start Date
March 1, 2018
Primary Completion Date
September 1, 2019
Completion Date
September 1, 2019
Last Updated
February 20, 2018
NCT02600949
NCT03050268
NCT06423326
NCT07542041
NCT04389632
NCT07283705
Lead Sponsor
Singapore General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions